05:13 PM EDT, 10/04/2024 (MT Newswires) -- Fouad Namouni, President, R&D, on October 03, 2024, sold 3,633 shares in Blueprint Medicines ( BPMC ) for $324,500. Following the Form 4 filing with the SEC, Namouni has control over a total of 69,070 shares of the company, with 69,070 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1597264/000141588924024776/xslF345X05/form4-10042024_091035.xml